Cancer Drug Discovery & Preclinical Development 2014

Key Topics

• Overcoming mechanisms of drug resistance with new targeted anti-cancer therapies
• Strategies for the identification of selective kinase inhibitors
• DNA-targeted agents as part of a personalised approach to drug discovery
• New therapeutic targets in epigenetics and newly described metabolic pathways
• Engineering antibodies for targeted cancer therapy
• Methods for establishing pharmacologically safe and effective dose in animal studies
• Preparing for exploratory development

Who should Attend

Team Leaders, Research Scientists, Managers, Heads, professionals and Directors working in the following areas related to oncology::

• Preclinical Development
• Drug Discovery
• Medicinal Chemistry
• Exploratory Development
• Formulation
• Computational chemistry
• Translational Medicine
• Targeted therapeutics
• Genetics
• Personalised medicine
• Data Management
• Regulatory Affairs
• More Information: